| E-Y0001194 |
EP |
【白藜芦醇（订货以英 |
Resveratrol |
|
20 mg |
1484.59 |
42 |
| E-Y0001193 |
EP |
【克拉珠利（订货以英 |
Clazuril |
|
10 mg |
1264 |
28 |
| E-Y0001192 |
EP |
【A型肝炎疫苗（灭活， |
Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP |
|
1 mL |
1881.18 |
42 |
| E-Y0001191 |
EP |
【加兰他敏合成系统 |
Galantamine synthetic for system suitability |
|
5 mg |
1264 |
28 |
| E-Y0001190 |
EP |
【加兰他敏自然系统 |
Galantamine natural for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001189 |
EP |
【噻托溴铵系统适应 |
Tiotropium for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001188 |
EP |
【噻托溴铵一水合合 |
Tiotropium bromide monohydrate |
|
10 mg |
1264 |
28 |
| E-Y0001187 |
EP |
【普拉克索系统适应 |
Pramipexole for system suitability |
|
15 mg |
1264 |
28 |
| E-Y0001186 |
EP |
【沙丁胺醇杂质J（订 |
Salbutamol impurity J |
|
0.00045 mg |
1264 |
28 |
| E-Y0001185 |
EP |
【马兜铃酸I（订货以 |
Aristolochic acid I |
|
11 mg |
1264 |
28 |
| E-Y0001184 |
EP |
【三乙醇胺杂质A（订 |
Trolamine impurity A |
|
250 mg |
1264 |
28 |
| E-Y0001183 |
EP |
【三乙醇胺杂质B（订 |
Trolamine impurity B |
|
1 ml |
1264 |
28 |
| E-Y0001182 |
EP |
【卡托普利系统适应 |
Captopril for system suitability |
|
20 mg |
1264 |
28 |
| E-Y0001181 |
EP |
【奥芬那君峰值鉴别 |
Orphenadrine for peak identification |
|
0.42 mg |
1264 |
28 |
| E-Y0001179 |
EP |
【噻托溴铵杂质混合 |
Tiotropium impurity mixture |
|
0.08 mg |
1264 |
28 |
粤公网安备 44010302000979号